Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 17, 2021

Neratinib in Older Adults With HER2-Amplified or HER2/3-Mutated Metastatic Breast Cancer

Journal of Geriatric Oncology


Additional Info

Journal of Geriatric Oncology
Phase II Study of Neratinib in Older Adults With HER2 Amplified or HER2/3 Mutated Metastatic Breast Cancer
J Geriatr Oncol 2021 Mar 02;[EPub Ahead of Print], Y Yuan, JS Lee, SE Yost, et al

Further Reading